Pegylated recombinant mammalian uricase (PEG-uricase)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated recombinant mammalian uricase (PEG-uricase), covering 2013-01-18 to 2013-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout [Phase 2]